Brexit

Brexit and Irish Pharma

The UK’s decision to leave the EU in Summer 2016 sent shockwaves throughout Europe and left neighbouring countries struggling to interpret what ‘Brexit’ means for them. Ireland, as the UK’s…

Brexit: A Window of Opportunity for France’s Drug Regulator?

As the UK prepares to leave the European Union in March 2019, stakeholders across the European life sciences…

Brexit: Much ado about nothing?

Brexit, Brexit, Brexit. It’s all anyone can talk about and yet nobody can tell you with certainty what to expect.…

EMA Headquarters to Move to Amsterdam

The European Medicines Agency (EMA), the EU body responsible for the evaluation of medicinal products for use…

In Conversation

Mike Thompson, chief executive of the Association of the British Pharmaceutical Industry (ABPI) reveals his staunch faith in the British health service but calls for the NHS to welcome and drive change by enhancing productivity. With positive evolutions in the UK government’s approach to collaborative partnerships, he warns that clarity for the industry in the next stage of Brexit talks…

Roche boss: Brexit will make the UK less competitive

Last week, Roche Boss Severin Schwan expressed concern that Brexit could further slow the UK drug approval process.…

Steven Lynch – Managing Director, British Chamber of Commerce in China

Steven Lynch, managing director of the British Chamber of Commerce in China, introduces the Chamber’s activities…

NEW Special Report on UK

Despite a myriad of uncertainties around its decision to leave the European Union, the UK still stands as one of…

Brexit uncertainty forces AstraZeneca to freeze investment in the UK

Yesterday, pharma giant AstraZeneca announced that they have halted investment in the UK due to lack of clarity on…

Pfizer’s Nordkamp Takes ABPI Presidency

Erik Nordkamp, managing director of Pfizer UK, has been confirmed as the new president of the Association of the…

Brexit Bites: EMA cuts off Britain

The European Medicines Agency has cut Britain out of its contracts 7 months ahead of Brexit. “You might have been…

UK Life Sciences Firms Struggle in Post-Brexit War for EU Talent

UK pharmaceutical and biotech companies are already finding it increasingly difficult to attract talent from…